Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Kohlmann

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Methods in Molecular Medicine|March 1, 2006
Classification of AML by DNA-oligonucleotide microarraysAlexander Kohlmann, Wolfgang Kern, Wolfgang Hiddemann, et al.
Reviews in Clinical and Experimental Hematology|July 20, 2005
Role of gene expression profiling for diagnosing acute leukemiasWolfgang Kern, Alexander Kohlmann, Susanne Schnittger, et al.
Cancer|October 17, 2006
Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemiasWolfgang Kern, Alexander Kohlmann, Claudia Schoch, et al.
Critical Reviews in Oncology/Hematology|June 9, 2007
Gene expression profiling in sarcomasKatharina Tschoep, Alexander Kohlmann, Marcus Schlemmer, et al.
Haematologica|November 12, 2009
Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosisJohanna Flach, Frank Dicker, Susanne Schnittger, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 20, 2007
[Microarrays and gene expression profiling for the diagnosis in leukemia. From research studies to routine application]Torsten Haferlach, Ulrike Bacher, Alexander Kohlmann, et al.
Genes, Chromosomes & Cancer|April 23, 2005
Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profileClaudia Schoch, Wolfgang Kern, Alexander Kohlmann, et al.
Annals of Hematology|March 3, 2010
Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignanciesUlrike Bacher, Claudia Haferlach, Susanne Schnittger, et al.
Genes, Chromosomes & Cancer|February 5, 2014
Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndromeSarah Volkert, Alexander Kohlmann, Susanne Schnittger, et al.
Genes, Chromosomes & Cancer|September 27, 2006
Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroupsClaudia Schoch, Alexander Kohlmann, Martin Dugas, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Methods in Molecular Medicine|March 1, 2006
Classification of AML by DNA-oligonucleotide microarraysAlexander Kohlmann, Wolfgang Kern, Wolfgang Hiddemann, et al.
Reviews in Clinical and Experimental Hematology|July 20, 2005
Role of gene expression profiling for diagnosing acute leukemiasWolfgang Kern, Alexander Kohlmann, Susanne Schnittger, et al.
Cancer|October 17, 2006
Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemiasWolfgang Kern, Alexander Kohlmann, Claudia Schoch, et al.
Critical Reviews in Oncology/Hematology|June 9, 2007
Gene expression profiling in sarcomasKatharina Tschoep, Alexander Kohlmann, Marcus Schlemmer, et al.
Haematologica|November 12, 2009
Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosisJohanna Flach, Frank Dicker, Susanne Schnittger, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 20, 2007
[Microarrays and gene expression profiling for the diagnosis in leukemia. From research studies to routine application]Torsten Haferlach, Ulrike Bacher, Alexander Kohlmann, et al.
Genes, Chromosomes & Cancer|April 23, 2005
Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profileClaudia Schoch, Wolfgang Kern, Alexander Kohlmann, et al.
Annals of Hematology|March 3, 2010
Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignanciesUlrike Bacher, Claudia Haferlach, Susanne Schnittger, et al.
Genes, Chromosomes & Cancer|February 5, 2014
Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndromeSarah Volkert, Alexander Kohlmann, Susanne Schnittger, et al.
Genes, Chromosomes & Cancer|September 27, 2006
Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroupsClaudia Schoch, Alexander Kohlmann, Martin Dugas, et al.
Pageof 11